Heterogenous Core-Shell Persistent Luminescent Nanoparticles with Enhanced Afterglow Luminescence.

Persistent luminescent nanoparticles (PLNPs) are promising for many bioapplications due to their unique afterglow luminescence following the stoppage of light excitation. However, PLNPs are prone to surface quenching that results in weak afterglow luminescence. Although some efforts have been made to reduce surface quenching through designing homogeneous core-shell PLNPs, the enhancement in afterglow luminescence was insignificant.

Nanomaterials for light-mediated therapeutics in deep tissue.

Light-mediated therapeutics, including photodynamic therapy, photothermal therapy and light-triggered drug delivery, have been widely studied due to their high specificity and effective therapy. However, conventional light-mediated therapies usually depend on the activation of light-sensitive molecules with UV or visible light, which have poor penetration in biological tissues. Over the past decade, efforts have been made to engineer nanosystems that can generate luminescence through excitation with near-infrared (NIR) light, ultrasound or X-ray.

Metal-Organic Frameworks (MOFs) and Their Composites as Emerging Biomaterials for Osteoarthritis Treatment.

Metal-Organic Frameworks (MOFs) have emerged as a novel component in biomaterial formulations over the past 5 years. The bioactivity of MOFs in bone or cartilage tissue is mediated through the sustained delivery of metal ions, bioactive ligands, or drug molecules that are loaded into the porous MOF structures. Alternatively, bioactivity may also originate from structure-specific properties.